An announcement from Aurora Spine ( (TSE:ASG) ) is now available.
Aurora Spine announced the publication of a biomechanical study in the journal Neurospine, demonstrating the superior performance of its SiLO TFX ™ Sacroiliac Fusion System compared to traditional methods. The study highlights the system’s ability to reduce joint motion and preserve bone integrity, offering a promising alternative for sacroiliac joint fusion. The findings support Aurora Spine’s commitment to optimizing patient outcomes and reinforce its position as a leader in spinal implant technology.
More about Aurora Spine
Aurora Spine is a company focused on developing innovative, minimally invasive, and regenerative spinal implant technologies. They aim to provide new solutions to the spinal implant market, enhancing spinal health through continuous innovation and collaboration with medical professionals.
YTD Price Performance: -12.50%
Average Trading Volume: 35,404
Technical Sentiment Signal: Hold
Current Market Cap: C$27.8M
For detailed information about ASG stock, go to TipRanks’ Stock Analysis page.